Expensive In, Narrow Out: Why China VC Barely Pays Today

2026 looks like a good year for Chinese venture capital. IPOs are returning, and the most visible AI and chip companies have produced eye-catching paper gains. I have invested in China’s private markets for more than a decade, but the question I keep coming back to is different: how much of that paper value will reach the people who financed the funds?

In the first half of 2026, seven companies accounted for 41% of the value of VC/PE holdings in newly listed Chinese companies, measured at their issue prices.¹ That concentration matters. My view is that, at today’s entry prices, many smaller independent managers and individual LPs are unlikely to earn net returns that justify the risk and a decade of illiquidity. This is a judgment about a particular part of the market, not a claim that no Chinese VC fund can perform well.

The tailwinds behind earlier vintages have weakened: cheap entry prices, consumer-internet scale, and relatively accessible overseas exits. The remaining prize is often an IPO valuation in a policy-favored sector. Competition for companies that might win that prize is already pushing up their private-market prices.

1. The exit must support the entry price

Chinese VCs can exit through IPOs, acquisitions, secondary sales, and buybacks. But I see many hot-sector deals priced as if a successful listing is the base case. A buyback may offer a contractual return, but it is worth only what the obligor can pay. An acquisition can return capital, yet its price depends on the buyer’s economics and the terms of the deal. If only an exceptional IPO can support the entry valuation, the investor has little room for an ordinary outcome.

There is a genuine policy opening. In June 2025, the CSRC expanded the STAR Market’s fifth listing standard to fields including AI, commercial aerospace, and the low-altitude economy.² That improves the listing path for some unprofitable technology companies. It does not make every company in those fields a liquid exit for its early backers: eligibility, valuation, lock-ups, and the eventual market for the shares still matter.

The United States offers a useful comparison, though the two markets have different rules and investor bases. The NVCA’s 2026 Yearbook records 49 US VC-backed IPOs and 1,396 acquisitions in 2025.³ That does not mean every acquisition produced a good return: fewer than one in seven disclosed its price. It does show a much broader route for companies that will never be public-market stars. I do not see an equally dependable acquisition route for the smaller Chinese funds I know.

The winners from an IPO reopening can be enormous. But I would not underwrite the next fund on the assumption that a policy window, an exceptional company, and a receptive public market will all arrive together.

2. Smaller managers are squeezed from both ends

The deals smaller managers can afford often struggle to exit; the deals with a credible IPO story can be priced beyond the returns those managers need.

Hot sectors are priced for extraordinary outcomes. I recently encountered an angel financing for a reusable-rocket startup at an RMB 4 billion pre-money valuation. At that entry price, even a fivefold return requires a very large exit valuation, and future dilution raises the bar further. I have seen similarly demanding entry prices in chip equipment. These are examples from my deal flow, not a representative sample of all transactions. The word angel says little about whether the risk is attractively priced.

Company growth is not investor return. MiniMax’s prospectus shows a rise of roughly 21 times in company valuation from its angel financing to its last private round.⁴ On a per-share basis, comparing the early financing prices with the midpoint of the IPO offer range gives a much smaller paper multiple for the angel round, and a still smaller one for the last private round. Those are marks, not cash distributions; financing terms, dilution, and the eventual sale price determine realized investor returns.

Time is a cost, not a footnote. Camsense’s Hong Kong listing documents trace its seed financing to June 2015.⁵ Even before considering what investors can actually sell and at what price, that is more than eleven years between that financing and the 2026 listing process. A typical fund term can expire while a successful portfolio company is still working toward liquidity.

These observations do not prove that all small managers lose money. They explain why I ask about exit timing and proceeds before I take a private valuation at face value.

3. State capital changes the incentives around price

Government guidance funds and state-owned investors are now central to Chinese private-market fundraising. A Deloitte industry survey says they supplied about 75% of the amount contributed by institutional LPs in 2025.⁶ That is a share of a particular fundraising measure, not a claim that the state owns 75% of every fund or deal.

Their mandates can include local investment and industrial development alongside financial return. A local reinvestment requirement can direct several managers toward the same limited pool of qualifying companies. In some deals I have seen, a recognizable lead investor and a buyback clause also help participants pass internal review. The clause may provide real protection if the obligor is solvent; it does not make a bad entry price safe.

Fujian’s 2025 fund policy illustrates both the incentives and a reform. It reduced a provincial fund’s minimum local reinvestment multiple from 1.5 to 1. The policy also allows certain failed investments to be exempted from accountability, subject to diligence, no improper benefit, and specified qualifying conditions. One qualifying case is following a national fund or a high-quality manager.⁷ That is a conditional process rule, not a blanket promise that price or performance never matters.

My concern is about the marginal bid. When capital is rewarded for meeting several goals at once, the price a financially driven fund needs may cease to set the market. A small manager who competes at the same price cannot assume it has the same objective function or the same tolerance for delay.

4. The individual LP gets what remains

A fivefold deal is not a fivefold fund. Imagine ten equal investments: two return 5x, three return 1x, and five return nothing. The portfolio returns 1.3x before fund costs: (2 × 5 + 3 × 1) ÷ 10. That is a useful check on the excitement generated by any single winner.

Fees, carried interest, taxes, and the timing of distributions can reduce the LP’s result further. The precise amount depends on the fund agreement, cash-flow dates, and the LP’s tax position. For a qualifying venture fund that elects single-fund tax accounting, China’s Ministry of Finance rules specify a 20% tax rate on an individual partner’s share of eligible equity-transfer and dividend income; management fees and carried interest are not deductible in that calculation.⁸ I would not turn that rule into a universal net-return table for every RMB fund. The right request to a GP is a cash-flow schedule showing what an individual LP actually receives, when, and after which charges and taxes.

Individual LPs may have less access to the strongest managers or co-investments and less ability to sell a small fund interest. Listed companies offer daily liquidity and transparent prices, though buying them after an IPO is a different investment with different risks. For someone weighing the two, the private fund needs to demonstrate an advantage after all of its costs and years of illiquidity.

I am not arguing that an individual should never invest in a private fund. I would want genuinely attractive entry prices, a GP with evidence of converting paper gains into cash, terms I can model, and money I can leave invested for longer than the stated fund life. Very few opportunities I see clear all four tests.

What would change my mind

I would revisit this view if:

• Acquisitions became a reliable route for mid-sized Chinese companies at prices that reward early risk.
• Fund reporting made individual LP net cash returns and the time to distribution easier to compare.
• Entry prices fell to levels that ordinary, rather than exceptional, exits could support.
• Liquidity improved for smaller Hong Kong listings after shareholder lock-ups end.

Until then, the most useful questions for a fund are straightforward: Is the entry price reasonable? Can the money survive the full development and financing cycle? And when the time comes, can paper value become cash for the LP?

Sources and notes

The numbered references document the numerical and policy claims above. Anonymous financing examples and observations about deal behavior are from my own experience and should be read as such. Prospectus valuations and IPO offer prices describe paper value, not realized fund or LP returns.